Diagnostic imaging in the management of patients with metabolic syndrome

Seo Rin Kim, Lilach O Lerman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster development of type 2 diabetes and cardiovascular disease. Abdominal obesity and insulin resistance play a prominent role among all metabolic traits of MetS. Because intervention including weight loss can reduce these morbidity and mortality in MetS, early detection of the severity and complications of MetS could be useful. Recent advances in imaging modalities have provided significant insight into the development and progression of abdominal obesity and insulin resistance, as well as target organ injuries. The purpose of this review is to summarize advances in diagnostic imaging modalities in MetS that can be applied for evaluating each components and target organs. This may help in early detection, monitoring target organ injury, and in turn developing novel therapeutic target to alleviate and avert them.

Original languageEnglish (US)
JournalTranslational Research
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Diagnostic Imaging
Insulin
Imaging techniques
Medical problems
Abdominal Obesity
Insulin Resistance
Monitoring
Wounds and Injuries
Type 2 Diabetes Mellitus
Weight Loss
Cardiovascular Diseases
Morbidity
Mortality

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Biochemistry, medical

Cite this

Diagnostic imaging in the management of patients with metabolic syndrome. / Kim, Seo Rin; Lerman, Lilach O.

In: Translational Research, 01.01.2017.

Research output: Contribution to journalArticle

@article{b47a28133bd74859bc0fa1f7ecae5dcb,
title = "Diagnostic imaging in the management of patients with metabolic syndrome",
abstract = "Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster development of type 2 diabetes and cardiovascular disease. Abdominal obesity and insulin resistance play a prominent role among all metabolic traits of MetS. Because intervention including weight loss can reduce these morbidity and mortality in MetS, early detection of the severity and complications of MetS could be useful. Recent advances in imaging modalities have provided significant insight into the development and progression of abdominal obesity and insulin resistance, as well as target organ injuries. The purpose of this review is to summarize advances in diagnostic imaging modalities in MetS that can be applied for evaluating each components and target organs. This may help in early detection, monitoring target organ injury, and in turn developing novel therapeutic target to alleviate and avert them.",
author = "Kim, {Seo Rin} and Lerman, {Lilach O}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.trsl.2017.10.009",
language = "English (US)",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Diagnostic imaging in the management of patients with metabolic syndrome

AU - Kim, Seo Rin

AU - Lerman, Lilach O

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster development of type 2 diabetes and cardiovascular disease. Abdominal obesity and insulin resistance play a prominent role among all metabolic traits of MetS. Because intervention including weight loss can reduce these morbidity and mortality in MetS, early detection of the severity and complications of MetS could be useful. Recent advances in imaging modalities have provided significant insight into the development and progression of abdominal obesity and insulin resistance, as well as target organ injuries. The purpose of this review is to summarize advances in diagnostic imaging modalities in MetS that can be applied for evaluating each components and target organs. This may help in early detection, monitoring target organ injury, and in turn developing novel therapeutic target to alleviate and avert them.

AB - Metabolic syndrome (MetS) is the constellation of metabolic risk factors that might foster development of type 2 diabetes and cardiovascular disease. Abdominal obesity and insulin resistance play a prominent role among all metabolic traits of MetS. Because intervention including weight loss can reduce these morbidity and mortality in MetS, early detection of the severity and complications of MetS could be useful. Recent advances in imaging modalities have provided significant insight into the development and progression of abdominal obesity and insulin resistance, as well as target organ injuries. The purpose of this review is to summarize advances in diagnostic imaging modalities in MetS that can be applied for evaluating each components and target organs. This may help in early detection, monitoring target organ injury, and in turn developing novel therapeutic target to alleviate and avert them.

UR - http://www.scopus.com/inward/record.url?scp=85036575495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036575495&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2017.10.009

DO - 10.1016/j.trsl.2017.10.009

M3 - Article

JO - Translational Research

JF - Translational Research

SN - 1931-5244

ER -